Your browser doesn't support javascript.
loading
Spatially Resolved Metabolites in Stable and Unstable Human Atherosclerotic Plaques Identified by Mass Spectrometry Imaging.
Seeley, Erin H; Liu, Zhipeng; Yuan, Shuai; Stroope, Chad; Cockerham, Elizabeth; Rashdan, Nabil A; Delgadillo, Luisa F; Finney, Alexandra C; Kumar, Dhananjay; Das, Sandeep; Razani, Babak; Liu, Wanqing; Traylor, James; Orr, A Wayne; Rom, Oren; Pattillo, Christopher B; Yurdagul, Arif.
Afiliación
  • Seeley EH; Department of Chemistry, University of Texas at Austin (E.H.S.).
  • Liu Z; Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, IN (Z.L.).
  • Yuan S; Heart, Lung, Blood and Vascular Medicine Institute, University of Pittsburgh, PA (S.Y.).
  • Stroope C; Department of Molecular and Cellular Physiology (C.S., N.A.R., L.F.D., D.K., A.W.O., O.R., C.B.P., A.Y.), LSU Health Sciences Center at Shreveport, LA.
  • Cockerham E; Department of Pathology and Translational Pathobiology (E.C., A.C.F., S.D., J.T., A.W.O., O.R., A.Y.), LSU Health Sciences Center at Shreveport, LA.
  • Rashdan NA; Department of Molecular and Cellular Physiology (C.S., N.A.R., L.F.D., D.K., A.W.O., O.R., C.B.P., A.Y.), LSU Health Sciences Center at Shreveport, LA.
  • Delgadillo LF; Department of Molecular and Cellular Physiology (C.S., N.A.R., L.F.D., D.K., A.W.O., O.R., C.B.P., A.Y.), LSU Health Sciences Center at Shreveport, LA.
  • Finney AC; Department of Pathology and Translational Pathobiology (E.C., A.C.F., S.D., J.T., A.W.O., O.R., A.Y.), LSU Health Sciences Center at Shreveport, LA.
  • Kumar D; Department of Molecular and Cellular Physiology (C.S., N.A.R., L.F.D., D.K., A.W.O., O.R., C.B.P., A.Y.), LSU Health Sciences Center at Shreveport, LA.
  • Das S; Department of Pathology and Translational Pathobiology (E.C., A.C.F., S.D., J.T., A.W.O., O.R., A.Y.), LSU Health Sciences Center at Shreveport, LA.
  • Razani B; Vascular Medicine Institute, Department of Medicine, University of Pittsburgh School of Medicine and UPMC, PA (B.R.).
  • Liu W; Pittsburgh VA Medical Center, PA (B.R.).
  • Traylor J; Department of Pharmaceutical Sciences and Department of Pharmacology, Wayne State University, MI (W.L.).
  • Orr AW; Department of Pathology and Translational Pathobiology (E.C., A.C.F., S.D., J.T., A.W.O., O.R., A.Y.), LSU Health Sciences Center at Shreveport, LA.
  • Rom O; Department of Molecular and Cellular Physiology (C.S., N.A.R., L.F.D., D.K., A.W.O., O.R., C.B.P., A.Y.), LSU Health Sciences Center at Shreveport, LA.
  • Pattillo CB; Department of Pathology and Translational Pathobiology (E.C., A.C.F., S.D., J.T., A.W.O., O.R., A.Y.), LSU Health Sciences Center at Shreveport, LA.
  • Yurdagul A; Department of Molecular and Cellular Physiology (C.S., N.A.R., L.F.D., D.K., A.W.O., O.R., C.B.P., A.Y.), LSU Health Sciences Center at Shreveport, LA.
Arterioscler Thromb Vasc Biol ; 43(9): 1626-1635, 2023 09.
Article en En | MEDLINE | ID: mdl-37381983
ABSTRACT

BACKGROUND:

Impairments in carbohydrate, lipid, and amino acid metabolism drive features of plaque instability. However, where these impairments occur within the atheroma remains largely unknown. Therefore, we sought to characterize the spatial distribution of metabolites within stable and unstable atherosclerosis in both the fibrous cap and necrotic core.

METHODS:

Atherosclerotic tissue specimens from 9 unmatched individuals were scored based on the Stary classification scale and subdivided into stable and unstable atheromas. After performing mass spectrometry imaging on these samples, we identified over 850 metabolite-related peaks. Using MetaboScape, METASPACE, and Human Metabolome Database, we confidently annotated 170 of these metabolites and found over 60 of these were different between stable and unstable atheromas. We then integrated these results with an RNA-sequencing data set comparing stable and unstable human atherosclerosis.

RESULTS:

Upon integrating our mass spectrometry imaging results with the RNA-sequencing data set, we discovered that pathways related to lipid metabolism and long-chain fatty acids were enriched in stable plaques, whereas reactive oxygen species, aromatic amino acid, and tryptophan metabolism were increased in unstable plaques. In addition, acylcarnitines and acylglycines were increased in stable plaques whereas tryptophan metabolites were enriched in unstable plaques. Evaluating spatial differences in stable plaques revealed lactic acid in the necrotic core, whereas pyruvic acid was elevated in the fibrous cap. In unstable plaques, 5-hydroxyindoleacetic acid was enriched in the fibrous cap.

CONCLUSIONS:

Our work here represents the first step to defining an atlas of metabolic pathways involved in plaque destabilization in human atherosclerosis. We anticipate this will be a valuable resource and open new avenues of research in cardiovascular disease.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Aterosclerosis / Placa Aterosclerótica Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Arterioscler Thromb Vasc Biol Asunto de la revista: ANGIOLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Aterosclerosis / Placa Aterosclerótica Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Arterioscler Thromb Vasc Biol Asunto de la revista: ANGIOLOGIA Año: 2023 Tipo del documento: Article